Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-25T19:24:02.020Z Has data issue: false hasContentIssue false
  • English
  • Français

Diffusion theory can be applied to antibodies attaching to ligand sites

Published online by Cambridge University Press:  17 February 2009

D. P. Wilson  and
D. L. S. McElwain
D. P. Wilson
Affiliation:
School of Mathematical Sciences, Queensland University of Technology, GPO Box 2434, Brisbane Qld 4001, Australia; e-mail: [email protected].
D. L. S. McElwain
Affiliation:
School of Mathematical Sciences, Queensland University of Technology, GPO Box 2434, Brisbane Qld 4001, Australia; e-mail: [email protected].
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Humoral immunity is that aspect of specific immunity that is mediated by B lymphocytes and involves the neutralising of disease-producing microorganisms, called pathogens, by means of antibodies attaching to the pathogen's binding sites. This inhibits the pathogen's entry into target cells. We present a master equation in both discrete and in continuous form for a ligand bound at n sites becoming a ligand bound at m sites in a given interaction time. To track the time-evolution of the antibody-ligand interaction, it is shown that the process is most easily treated classically and that in this case the master equation can be reduced to an equivalent one-dimensional diffusion equation. Thus well-known diffusion theory can be applied to antibody-ligand interactions. We consider three distinct cases depending on whether the probability of antibody binding compared to the probability of dissociation is relatively large, small or comparable, and numerical solutions are given.

Type
Research Article
Information
The ANZIAM Journal , Volume 46 , Issue 4 , April 2005 , pp. 495 - 505
Copyright
Copyright © Australian Mathematical Society 2005

References

[1]Bentz, J., Nir, S. and Covell, D. G., “Mass action kinetics of virus-cell aggregation and fusion”, Biophys. J. 54 (1988) 449–462.CrossRefGoogle ScholarPubMed
[2]Cogne, M., “Humoral immunity. B lymphocytes; immunoglobulins (structure, diversity, function); clinical practice investigations; concept of humoral immunity deficiency”, La Revue Du Praticien 51 (2001) 193–202.Google ScholarPubMed
[3]Dembo, M. and Goldstein, B., “Theory of equilibrium binding of symmetric bivalent haptens to cell surface antibody: Application to histamine release from basophils”, J. Immunol. 121 (1978) 345–353.CrossRefGoogle ScholarPubMed
[4]Fewtrell, C. and Metzger, H., “Larger oligomers of IgE are more effective than dimers in stimulating rat basophilic leukemia cells”, J. Immunol. 125 (1980) 701–710.CrossRefGoogle ScholarPubMed
[5]Hlavacek, W. S., Posner, R. G. and Perelson, A. S., “Steric effects on multivalent ligand-receptor binding: Exclusion of ligand sites by bound cell surface receptors”, Biophys. J. 76 (1999) 3031–3043.CrossRefGoogle ScholarPubMed
[6]Keck, J. and Carrier, G., “Diffusion theory of nonequilibrium dissociation and recombination”, J. Chem. Phys. 43 (1965) 2284–2298.CrossRefGoogle Scholar
[7]MacGlashan, D. W., Peters, S. P., Warner, J. and Lichtenstein, L. M., “Characteristics of human basophil sulfide peptide leukotriene release: Releasability defined as the ability of the basophil to respond to dimeric cross-links”, J. Immuno 136 (1986) 2231–2239.CrossRefGoogle Scholar
[8]McKee, C. S., “Detailed balancing”, Applied Catalysis A: General 154 (1997) N2–N3.CrossRefGoogle Scholar
[9]Ohlberger, M. and Rohde, C., “Adaptive finite volume approximations fo weakly coupled convection dominated parabolic systems”, IMA J. Numerical Anal. 22 (2002) 253–280.CrossRefGoogle Scholar
[10]Perelson, A. S., “A model for antibody mediated cell aggregation: rosette formation”, in Mathematics and computers in biomedical applications (eds. Eisenfeld, J. and DeLisi, C.), (Elsevier, New York, 1985) 31–37.Google Scholar
[11]Perelson, A. S. and DeLisi, C., “Receptor clustering on a cell surface. I. Theory of receptor crosslinking by ligands bearing two chemically identical functional groups”, Math. Biosci. 49 (1980) 87–110.CrossRefGoogle Scholar
[12]Posner, R. G., Wofsy, C. and Goldstein, B., “The kinetics of bivalent ligand-bivalent receptor ggregation: ring formation and the breakdown of the equivalent site approximation”, Math. Biosci. 126 (1995) 171–190.CrossRefGoogle Scholar
[13]Rundell, A., DeCarlo, R., HogenEsch, H. and Doerschuk, P., “The humoralimmune response to haemophilus influenzae Type b: A mathematical model based on T-zone andgerminal center B-cell dynamics”, J. Theor Biol. 194 (1998) 341–381.CrossRefGoogle Scholar
[14]Schweitzer-Stenner, R., Licht, I., Luscher, I. and Pecht, I., “Dimerization kinetics of the IgE-class antibodies by divalent haptens. II. The interaction betweeintact 1gE and haptens”, Biophys. J. 63 (1987) 563–568.CrossRefGoogle Scholar
[15]Slifka, M. K., “Mechanisms of humoral immunity explored through studies of LCMV infection”, Current Topics in Microbiology and Immunology 263 (2002) 67–81.Google ScholarPubMed
[16]Slifka, M. K., Antia, R., Whitmire, J. K. and Ahmed, R., “Humoral immunity due to long-lived plasma cells”, Immnunity 8 (1998) 363–372.CrossRefGoogle ScholarPubMed
[17]Smirnova, O. A., “Study of cyclic kinetics of immunity by mathematical modeling methods”, Kosmicheskaia Biologiia i Aviakosmicheskaia Meditsina 25 (1991) 53–56.Google ScholarPubMed
[18]Sobottka, I.. Iglauer, F., Schuler, T., Schmetz, C., Visvesvara, G. S., Albrecht, H. -I., Schwartz, D. A., Pieniazek, N. J., Bartscht, K., Laufs, R. and Schottelius, J., “Acute and long-term humoral immunity following active immunization of rabbits with inactivated spores of various Encephalitozoon species”, Parasitology Research 87 (2001) 1–6.CrossRefGoogle ScholarPubMed
[19]Stewart, P. L., Chiu, C. Y., Huang, S., Muir, T., Zhao, Y., Chait, B., Mathias, P. and Nemerow, G. R., “Cryo-EM visualization of an exposed RGD epitope on advenovirus that escapes antibody neutralization”, EMBO J. 16 (1997) 1189–1198.CrossRefGoogle Scholar
[20]Su, H., Spangrude, G. J. and Caldwell, H. D., “Expression of Fc-γRIII on Hela 229 cells: possible effect on in vitro neutralization of chlainydia trachoinaris”, Infect. lmmun. 59 (1991) 3811–3814.CrossRefGoogle Scholar
[21]Surovtsev, I. V., Razumov, I. A., Nekrasov, V. M., Shvalov, A. N., Soin, J. T., Maltsev, V. P., Pctrov, A. K., Loktcv, V. B. and Chernyshev, A. V., “Mathematical modeling the kinetics of cell distribution in the process of ligand-receptor binding”, J. Theor. Biol. 206 (2000) 407–417.CrossRefGoogle ScholarPubMed